🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 15 of 78

  1. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10933076

    Crocin-sorafenib combination therapy for liver cancer

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10925874

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10927088

    Thymoquinone derivatives for treatment of cancer

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10927374

    Compositions and methods for controlling arthropod parasite and pest infestations

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10925969

    Anti-BCMA polypeptides and proteins

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10919939

    Mu opioid receptor agonist analogs of the endomorphins

    Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10912741

    Prevention of liver cancer with safranal-based formulations

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10913711

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10913785

    Anti-human papillomavirus 16 E6 T cell receptors

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10913709

    STAT3 inhibitor formulation

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10912797

    Tumor infiltrating lymphocytes and methods of therapy

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10907151

    Compositions and methods for treating or preventing lupus

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10905710

    Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10906940

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10906914

    Furoquinolinediones as inhibitors of TDP2

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10905769

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10899829

    Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10898583

    Harnessing quantum dots to study, visualize, and promote immune tolerance

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10898511

    Materials and methods relating to stabilised polymeric silicate compositions

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10898565

    Compositions, methods and uses for dengue virus serotype-4 constructs

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10899710

    Pyridines and their use in the treatment of cancer

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10900042

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10898566

    Zika virus vaccines

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10894816

    Use of IL-15 to increase thymic output and to treat lymphopenia

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10894073

    Pinot noir grape products for nonalcoholic fatty liver disease and other uses

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10894966

    Virus-based expression vectors and uses thereof

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10894077

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10888558

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10888565

    Compounds and compositions for ossification and methods related thereto

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10882886

    Adeno-associated virus polynucleotides, polypeptides and virions

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10881684

    Artificial invaplex formulated with deacylated lipopolysaccharide

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10882895

    Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10881653

    Tricyclic compounds and their use in the treatment of cancer

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10881698

    Diagnosis and treatment for respiratory tract diseases

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10881669

    Inhibitors of the plasmodial surface anion channel as antimalarials

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10881722

    Epizootic hemorrhagic disease vaccine

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10875907

    Filovirus antibody

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10876123

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10876003

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10875860

    Azaindenoisoquinoline compounds and uses thereof

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10869920

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10870687

    Anti-human papillomavirus 16 E7 T cell receptors

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10869865

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10869866

    Benzathine analogs

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10869851

    Targeting NUR77 for mitigating perinatal neuroinflammation

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10869856

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10864285

    Methods for the diagnosis and treatment of Sjögren's syndrome

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.